Metformin Versus Placebo from First Trimester to Delivery in Polycystic Ovary Syndrome: A Randomized, Controlled Multicenter Study
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
CONTEXT: Metformin is widely prescribed to pregnant women with polycystic ovary syndrome (PCOS) in an attempt to reduce pregnancy complications. Metformin is not approved for this indication, and evidence for this practice is lacking. OBJECTIVES: Our objective was to test the hypothesis that metformin, from first trimester to delivery, reduces pregnancy complications in women with PCOS. DESIGN AND SETTING: We conducted a randomized, placebo-controlled, double-blind, multicenter study at 11 secondary care centers. PARTICIPANTS: The participants were 257 women with PCOS, in the first trimester of pregnancy, aged 18-42 yr. INTERVENTION: We randomly assigned 274 singleton pregnancies (in 257 women) to receive metformin or placebo, from first trimester to delivery. MAIN OUTCOME MEASURES: The prevalence of preeclampsia, gestational diabetes mellitus, preterm delivery, and a composite of these three outcomes is reported. RESULTS: Preeclampsia prevalence was 7.4% in the metformin group and 3.7% in the placebo group (3.7%; 95% CI, -1.7-9.2) (P=0.18). Preterm delivery prevalence was 3.7% in the metformin group and 8.2% in the placebo group (-4.4%; 95%, CI, -10.1-1.2) (P=0.12). Gestational diabetes mellitus prevalence was 17.6% in the metformin group and 16.9% in the placebo group (0.8%; 95% CI, -8.6-10.2) (P=0.87). The composite primary endpoint prevalence was 25.9 and 24.4%, respectively (1.5%; 95% CI, -8.9-11.3) (P=0.78). Women in the metformin group gained less weight during pregnancy compared with those in the placebo group. There was no difference in fetal birth weight between the groups. CONCLUSIONS: Metformin treatment from first trimester to delivery did not reduce pregnancy complications in PCOS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Randomized, double-blind, controlled trials comparing metformin with other therapies for ovulation induction in individuals with polycystic ovary syndrome have not demonstrated benefit in preventing spontaneous abortion or GDM (91),”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [91]
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Knochenhauer, E. S., Key, T. J., Kahsar-Miller, M., Waggoner, W., Boots, L. R., & Azziz, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5090 · Cited by 1,516
Asunción, M., Calvo, R. M., San Millán, J. L., Sancho, J., Avila, S., & Escobar-Morreale, H. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6682 · Cited by 1,318
Metformin versus insulin for the treatment of gestational diabetes
Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707193 · Cited by 1,291
Knochenhauer, E. S. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.9.3078 · Cited by 1,127
Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome
Legro, R. S., Barnhart, H. X., Schlaff, W. D., Carr, B. R., Diamond, M. P., Carson, S. A., Steinkampf, M. P., Coutifaris, C., McGovern, P. G., Cataldo, N. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063971 · Cited by 1,027
A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome
Boomsma, C. M., Eijkemans, M. J. C., Hughes, E. G., Visser, G. H. A., Fauser, B. C. J. M., & Macklon, N. S. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml036 · Cited by 852
Cited by
Items 201–300 of 316
Espnes, K. A., Hønnås, A., Løvvik, T. S., Gundersen, P. O. M., Naavik, A., Skogvoll, E., Westin, A. A., Spigset, O., & Vanky, E. (2021) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13703 · Cited by 6
“Pooled data from randomized controlled trials from our research group indicate that metformin treatment during pregnancy reduces the risk of late miscarriage and preterm birth.(10,11) Its mechanisms of action in pregnancy are unclear.”
MethodSelf-citationLiu, J., Shen, L., Nguyen‐Hoang, L., Zhou, Q., Wang, C. C., Lu, X., Sahota, D. S., Chong, K. C., Ying, H., Gu, W., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-074493 · Cited by 7
Chang, Y.-T., Chen, M.-J., Lin, W., Lin, C., & Chang, J. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm14010123 · Cited by 10
“However, other studies have not shown improvement [31].”
Brzozowska, M. M., Puvanendran, A., Bliuc, D., Zuschmann, A., Piotrowicz, A. K., & O’Sullivan, A. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1119134 · Cited by 13
Atkins, P., TOMLINSON, G. A., Feig, D. S., & MiTy Collaborative Group (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3713 · Cited by 8
“13,14 Interpreting this finding with caution, it can be stated that metformin may not be as protective against macrosomia in the setting of comorbid PCOS and T2DM than previously anticipated, and further research will be required to confirm this finding.”
BackgroundResultObesity in Polycystic Ovary Syndrome: Insulin Sensitizing Therapy
Hoeger, K. M. (2012) · Current Obesity Reports · doi:10.1007/s13679-012-0030-y · Cited by 6
Predictors of Preeclampsia in Women in the Metformin in Gestational Diabetes(Mig) Study
Barrett, H. L. (2014) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000395 · Cited by 7
“However, this finding is not universal and other studies in PCOS, type 2 diabetes mellitus and GDM have not reported the same association [32-34].”
ResultUterine Artery Doppler in Pregnancy: Women with PCOS Compared to Healthy Controls
Stridsklev, S., Salvesen, Ø. O., Salvesen, K. Å., Carlsen, S. M., & Vanky, E. (2018) · International Journal of Endocrinology · doi:10.1155/2018/2604064 · Cited by 6
“A detailed description is published elsewhere [21].”
BackgroundMethodInfluentialSelf-citationPostpartum weight retention in women with polycystic ovary syndrome
Lee, I. T., Alur-Gupta, S., Gallop, R., & Dokras, A. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.07.033 · Cited by 7
Alenzi, E. O. (2020) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2020.1819796 · Cited by 7
Obesity, maternal smoking and SHBG in neonates
Dharashivkar, S., Wasser, L., Baumgartner, R., King, J. C., & Winters, S. J. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0158-0 · Cited by 5
“Cord blood SHBG levels were higher when pregnant women with PCOS were treated with metformin than with placebo [13] The concept of fetal programming has been gaining momentum with increasing evidence that the intrauterine milieu influences disease development later in life [14].”
BackgroundThe Prevention of Gestational Diabetes
Giugliano, E., & Caserta, B. G. D. (2013) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000286 · Cited by 7
Features of the course of pregnancy in women with polycystic ovary syndrome
Nikolayenkov, I. P., Kuzminykh, T. U., Tarasova, M. A., & Seryogina, D. S. (2020) · Journal of obstetrics and women s diseases · doi:10.17816/jowd695105-112 · Cited by 5
“В многоцентровом исследовании, направленном на оценку эффективности метформина с целью уменьшения частоты и выраженности осложнений беременности у больных СПЯ, было продемонстрировано, что заболеваемость ГСД в группах с использованием метформина и плацебо составила 17,6 и 16,9 % соответственно [46].”
Metformin as adjuvant therapy to IVF in women with PCOS: when is intention-to-treat unintentional?
Legro, R. S. (2011) · Human Reproduction · doi:10.1093/humrep/der155 · Cited by 4
“women with PCOS was also terminated early due to similar reasons (Vanky et al., 2010), including that the standard of care had switched during the trial to give all women with PCOS metformin during preg-”
ResultRyssdal, M., Skage, J. E., Jarmund, A. H., Hanem, L. G. E., Løvvik, T. S., Giskeødegård, G. F., Iversen, A., & Vanky, E. (2025) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.18320 · Cited by 5
“This study includes two study populations: (1) pregnant women with PCOS from the PregMet [26] and PregMet2 [15] studies (Figure S1) and (2) offspring of women with PCOS (recruited from the Pilot study [27] and the PregMet study [26]) who participated in a follow-up study termed the PedMet study…”
InfluentialSelf-citationPolycystic ovary syndrome: the strategy of diagnosis and treatment
Олеговна, Д. С. (2014) · Russian Journal of Human Reproduction · doi:10.17116/repro201420610-17 · Cited by 3
“В то же время, последующее более широкое мультицентровое исследование, выполненное этой же научной группой [24], не подтвердило эффективСтратегия обследования и лечения при СПКЯ”
Jungheim, E. S., & Okoroafor (2012) · Patient Preference and Adherence · doi:10.2147/ppa.s25286 · Cited by 3
“In the 1990s, metformin was identified as a solution to such cases and gained popularity as a first-line alternative to CC because it was thought to improve metabolic functioning while decreasing the risk PCOS in patients who faced developing gestational diabetes during pregnancy.(8,9,26) Numerous studies have emerged…”
BackgroundNeola, D., Angelino, A., Sirico, A., Murolo, C., Bartolini, G., Vigilante, L., Raffone, A., Carbone, L., Sarno, L., Saccone, G., et al. (2024) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.15728 · Cited by 3
“Vanky et al., 17 with a pilot study and two subsequent randomized trials 18,19 showed that metformin plays a positive role in lowering some risks of pregnant women with PCOS.”
Romeo, P., D’Anna, R., & Corrado, F. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13185387 · Cited by 4
“Early data were conflicting: Fougner [35] and Vanky [36] found no effect on glucose homeostasis and reduced incidence of GDM (17.6% in the metformin group and 16.9% in the placebo group p = 0.87).”
InfluentialMetformin und das Syndrom der polyzystischen Ovarien
Geyter, C. D., Emch, F. H., & Ahler, A. (2018) · Gynäkologische Endokrinologie · doi:10.1007/s10304-018-0194-y · Cited by 3
Zhang, L., Chen, A., Lü, J., Ren, L., & Hu, Z. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-01061-3 · Cited by 4
Is metformin effective and safe during pregnancy in women with PCOS? An overview of reviews
Palomba, S., Seminara, G., Costanzi, F., Sculli, M. A., Alessi, E., Caserta, D., & Aversa, A. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2574334 · Cited by 7
“Otherwise, nausea, vomiting, abdominal pain and bloating were not significantly higher in the intervention group compared to placebo [36,37] and remained stable throughout pregnancy [37].”
InfluentialMetformin in High Metabolic Risk Pregnancies — A Patient-Level Meta-Analysis
Mousa, A., Løvvik, T. S., Carlsen, S., Belsti, Y., Enticott, J., Tay, C. T., Nikkinen, H., Morin-Papunen, L. C., Tertti, K., Rönnemaa, T., et al. (2026) · NEJM Evidence · doi:10.1056/evidoa2500337 · Cited by 2
Self-citationTherapieoptionen bei polyzystischem Ovarsyndrom mit oder ohne Kinderwunsch
Wallwiener, L.-M., Rösner, S., Goeckenjan, M., Strowitzki, T., & Tóth, B. (2011) · Gynäkologische Endokrinologie · doi:10.1007/s10304-010-0399-1 · Cited by 3
Ujvári, D., Trouva, A., Hirschberg, A. L., & Vanky, E. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-073619 · Cited by 4
“Conclusions S-PROK1, in the second trimester, did not predict pregnancy-induced hypertension, pre-eclampsia, or late miscarriage/preterm delivery in pregnant women with PCOS. s-PROK1 was lower in women who used metformin at conception.”
BackgroundSelf-citationTrouva, A., Alvarsson, M., Calissendorff, J., Åsvold, B. O., Ujvári, D., Hirschberg, A. L., & Vanky, E. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1388473 · Cited by 2
Self-citationLiu, H., Liu, Y., Wei, C., Zhang, S., & Xu, Y. (2024) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-024-03760-z · Cited by 2
“However, the effect of metformin on preventing GDM in women with PCOS is controversial [10, 11, 13–15].”
Oral antidiabetic agents in gestational diabetes: a narrative review of current evidence
Singh, A. K., & Singh, R. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.982090 · Cited by 2
“01) and less maternal weight gain in the metformin arm [71]”
BackgroundInsulin, other hypoglycemic drugs, and glucagon
Page, R. C. (2010) · Side effects of drugs annual · doi:10.1016/s0378-6080(10)32042-3 · Cited by 2
The effect of exercise and metformin treatment on circulating free DNA in pregnancy
Christiansen, S. C., Vanky, E., Klungland, H., Stafne, S. N., Mørkved, S., Salvesen, K. Å., Sæther, M., & Carlsen, S. M. (2014) · Placenta · doi:10.1016/j.placenta.2014.09.010 · Cited by 4
Self-citationMaternal and fetal insulin levels at birth in women with PCOS
Pasquali, R. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.61 · Cited by 2
Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2014) · The Scientific Issues of Ternopil Volodymyr Hnatiuk National Pedagogical University Series pedagogy · doi:10.18370/2309-4117.2014.20.22-35 · Cited by 2
Management Options for Infertile Women with Polycystic Ovary Syndrome
Mariani, G., & Bellver, J. (2018) · US Endocrinology · doi:10.17925/use.2018.14.2.67 · Cited by 3
Polyzystisches Ovarsyndrom (PCOS)
Neumann, K., & Griesinger, G. (2019) · Springer Reference Medizin · doi:10.1007/978-3-662-57636-6_7 · Cited by 3
Ibáñez, L., & de Zegher, F. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30060-9 · Cited by 2
Thompson, D. M., Berger, H. M., Feig, D. S., Gagnon, R. J., Kader, T., Keely, E., Kozak, S. E., Ryan, E. A., Sermer, M., & Vinokuroff, C. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.07.040 · Cited by 8
Polycystic ovary syndrome and pregnancy
Galazis, N. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv053 · Cited by 2
“…concluded there was a reduction of GDM in women with PCOS treated with metformin prophylactically (Zhu et al., 2014), the only randomized-controlled trial (RCT) conducted, revealed insignificant difference in the incidence of GDM between the metformin and the placebo groups (Vanky et al., 2010).”
BackgroundAdvances in Oral Anti‐Diabetes Drugs in Pregnancy
Mukerji, G., & Feig, D. S. (2017) · A Practical Manual of Diabetes in Pregnancy · doi:10.1002/9781119043805.ch15 · Cited by 2
Treatment of polycystic ovary syndrome: recent trial results
Ganie, M. A., Chakraborty, S., & Rehman, H. (2015) · Clinical Investigation · doi:10.4155/cli.14.133 · Cited by 3
PCOS Patients Needs Much More than Just Pills from Doctors
Mani, A. (2016) · Journal of General Practice · doi:10.4172/2329-9126.1000251 · Cited by 1
“The safety of duration of metformin administration during pregnancy and its effectiveness is still not established [7].”
BackgroundIs the Endometrium in Women with PCOS Compromised?
Piltonen, T. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108236263.022 · Cited by 1
Shestakova, M. V., Mel'nichenko, G. A., Andreeva, E. N., Sukhareva, O. Y., Vorotnikova, S. Y., Ibragimova, L. I., Фархадовна, Б. Ф., Demidova, T. Y., Геннадьевна, Д. Е., Tiselko, A. V., et al. (2024) · Diabetes Mellitus · doi:10.14341/dm13161 · Cited by 2
Role of Metformin in Preeclampsia: A Systematic Review
Anuja, M., Arthy, M., Jha, N., Ashok, M., Jha, A. K., & Sivaranjani, P. (2025) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-025-02194-6 · Cited by 3
“In contrast, Eszter Vanky et al. (2010) [20] found no significant reduction in preeclampsia risk with metformin in women with PCOS, although insulin sensitivity improved.”
Costa, D. N., Malek, R., & Davis, S. N. (2025) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2025.2545929 · Cited by 2
“PregMet and PregMet2 studies from Norway observed less weight gain in the metformin group compared to placebo, while a study from Pakistan reported similar weight gain between the groups [130,133,134].”
Husby, A. E., Simpson, M. R., Dalbye, R., Løvvik, T. S., & Vanky, E. (2026) · International Breastfeeding Journal · doi:10.1186/s13006-026-00843-8 · Cited by 1
“The PregMet study [24] (2005–2009) included 274 women and found no effect of metformin on pregnancy complications in women with PCOS.”
Self-citationPotential mechanisms contributing to gestational diabetes and pre-eclampsia in the obese woman
Sattar, N. A., & Freeman, D. J. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511782466.006 · Cited by 1
The Impact of Polycystic Ovarian Syndrome on Gestational Diabetes
Aust, S., & Ott, J. (2011) · InTech eBooks · doi:10.5772/23795 · Cited by 1
“However, a relevant reduction of obstetrical complications due to metformin treatment could not be verified in a recent randomized and controlled multicenter study (Vanky et al., 2010).”
BackgroundKwak, D. W., Yoo, I. S., & Choi, J.-S. (2013) · PERINATOLOGY (구 대한주산의학회잡지) · doi:10.14734/kjp.2013.24.2.95 · Cited by 1
Use of metformin during pregnancy for women with polycystic ovary syndrome
Fan, H. S. (2013) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2013.31021 · Cited by 2
“However, this area currently lacks investigation from large scale RCTs, and more evidence from such trails are required before more definitive conclusions can be drawn.”
BackgroundMethodResultInfluentialConsiderations and Challenges for Pregnancy in Polycystic Ovary Syndrome
Han, C. S., & Werner, E. F. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8394-6_15 · Cited by 1
Zaburzenia gospodarki węglowodanowej u kobiet z zespołem wielotorbielowatych jajników (PCOS)
Kuligowska-Jakubowska, M. (2012) · Cited by 1
Ornoy, A., & Weber-Schöndorfer, C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-408078-2.00016-0 · Cited by 1
Insulin, other hypoglycemic drugs, and glucagon
Page, R. C. L. (2012) · Side effects of drugs annual · doi:10.1016/b978-0-444-59499-0.00042-8 · Cited by 2
Frequency of Pre-Eclampsia in Obese pregnant Females taking Metformin during Pregnancy
Wajid, R., Zubair, Z., Parveen, A., Ammara, & Masood, S. (2023) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs202317319 · Cited by 1
Management of associated risks of pregnancy in polycystic ovary syndrome
Sheikh, L., Islam, Z. S., & Najmi, N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87932-3.00029-3 · Cited by 1
Elucidating metformin action on the ovary and fertility in healthy mice
Velázquez, C., Bordaquievich, M., Herrero, Y., Cohen, D. J., Bianchi, M. S., Cuasnicu, P. S., Prost, K., Pascuali, N., Parborell, F., & Abramovich, D. (2024) · Reproduction · doi:10.1530/rep-24-0229 · Cited by 1
Ovulation induction in anovulatory PCOS women
DIAMANTI, M., & Marca, A. L. (2025) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.24.05633-1 · Cited by 4
Homburg, R. (2014) · Springer eBooks · doi:10.1007/978-3-319-05612-8_10 · Cited by 1
Palomba, S., & Fauser, B. C. J. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-45534-1_22 · Cited by 1
Fasanella, D. R., Benner, S. L., Tejada, F. R., & Jackson-Ayotunde, P. L. (2019) · Side effects of drugs annual · doi:10.1016/bs.seda.2019.08.012 · Cited by 1
Physical exercise and metformin in the prevention of pre-eclampsia: systematic review
do Nascimento, I. B., Nunes, M. M., & Fleig, R. (2020) · Fisioterapia em Movimento · doi:10.1590/1980-5918.033.ao41 · Cited by 2
Spezielle Arzneimitteltherapie in der Schwangerschaft
(2012) · Elsevier eBooks · doi:10.1016/b978-3-437-21203-1.10002-0 · Cited by 1
“Vanky et al. (2010) führten eine randomisierte, placebokontrollierte Doppelblindstudie an 257 PCOS-erkrankten Schwangeren durch, die bis zur Entbindung Metformin (n = 135) oder ein Placebo (n = 138) ein- 4032.15.12 Estrogene 2 Sc hw an ge rs ch af t 2.”
InfluentialPolycystic ovary syndrome and fertility
Goldenberg, N., & Glueck, C. J. (2013) · doi:10.2217/ebo.12.175 · Cited by 1
Infertility and reproductive endocrinology
Bieber, E. J., Sanfilippo, J. S., Horowitz, I., & Shafi, M. I. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139628938.058 · Cited by 1
Cell type-specific placental signatures in polyendocrine metabolic ovary syndrome and metforminPreprint
Jiang, H., Wang, X., Vanky, E., Parreira, D., Derisoud, E., Jannig, P. R., Nordenhök, E., Zhao, A., Li, C., Stridsklev, S., et al. (2026) · medRxiv · doi:10.64898/2026.05.21.26353338 · Cited by 1
Self-citationBedeutung der Insulinresistenz beim polyzystischen Ovarsyndrom – prä- und postkonzeptionell
Edimiris, P., Kimmig, R., & Köninger, A. (2015) · Der Gynäkologe · doi:10.1007/s00129-015-3788-7
Pregnancy in PCOS Women and their History of Diabetes
Lauszus, M. G. F. F. (2014) · Journal of Metabolic Syndrome · doi:10.4172/2167-0943.1000163
“GDM; preeclampsia, preterm delivery [3].”
BackgroundResultInfluentialDardzińska, J. A., & Rachoń, D. (2012) · Endokrynologia, Otyłość i Zaburzenia Przemiany Materii · Cited by 1
Effect of Metformin on Diabetes Mellitus Prevention in Pregnant Women with Risk Factors
Niroomanesh, S., Dadashaliha, M., Ahmadi, F. S., Sherbaf, F. R., & Forghani, F. (2010) · DOAJ (DOAJ: Directory of Open Access Journals)
Metformin in gestational diabetes mellitus
Tertti, K. (2013) · UTUPub (University of Turku)
Lauszus, F. F. (2014) · Andrology & Gynecology Current Research · doi:10.4172/2327-4360.1000128
“in their randomized study could not find such an androgen lowering effect in the metformin treated group [13,14].”
BackgroundMetformin under svangerskapet påvirker fosteret
Hem, E. (2013) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.13.0083
The effect of metformin on pregnancy outcome among filipino women with polycystic ovary syndrome
Uyking-Naranjo, M., Consencino, E. P., Mirasol, R. C., & Tan-Garcia, J. (2013) · Endocrine Abstracts · doi:10.1530/endoabs.32.p600
Nair, A. R. (2016) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v4i5.21
Weniger Gewichtszunahme bei adipösen Schwangeren mit Metformin
Stupin, J. H. (2016) · Info Diabetologie · doi:10.1007/s15034-016-0867-3
Takoudes, T. C. (2017) · Springer eBooks · doi:10.1007/978-3-319-39328-5_3
Links Between Polycystic Ovary Syndrome and Gestational Diabetes Mellitus
Trouva, A., & Diamanti‐Kandarakis, E. (2017) · Springer eBooks · doi:10.1007/978-3-319-56440-1_16
OS EFEITOS DA METFORMINA NA OBESIDADE DA GESTANTE E NO PESO DO RECÉM-NASCIDO
do Nascimento, I. B., Dienstmann, G., de Souza, M. L. R., Fleig, R., & Silva, J. C. (2017) · Saúde e Pesquisa · doi:10.17765/1983-1870.2017v10n2p373-382
Appropriate use of metformin in early pregnancy: is there a role for first trimester use?
Panidis, D., & Τζιόμαλος, Κ. (2013) · doi:10.2217/ebo.12.187
Kinder von Schwangeren mit Metformin sind dicker als normal
Stupin, J. H. (2018) · Info Diabetologie · doi:10.1007/s15034-018-1308-2
Castillo-Castro, C., Gonzalez-Velazquez, C. D., & Rodríguez‐Gutiérrez, R. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00884
Diagnostik und Therapie habitueller Aborte – die S2k-Leitlinie 2018 in der Praxis
Antoniadis, S., Lotz, L., & Cupisti, S. (2018) · Frauenheilkunde up2date · doi:10.1055/a-0607-0088
“Eine aussagekräftige Untersuchung und korrekte Interpretation der Ergebnisse ist deshalb frühestens 6 Wochen nach einer Schwangerschaft möglich.”
BackgroundInfluentialWitkop, C. T. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814823-5.00027-1 · Cited by 1
Update 2014 zu Diabetes und Schwangerschaft
Kleinwechter, H. J. (2014) · Der Diabetologe · doi:10.1007/s11428-013-1191-3 · Cited by 1
증례 : 임신 20주경까지 안지오텐신 수용체차단제를 포함한 혈압약과 경구 당뇨병 약제를 지속적으로 복용하고 심한 양수과소증으로 진단된 산모에서 만삭 정상 분만한 1예
유인석, 최준식, & 곽동욱 (2013) · PERINATOLOGY (구 대한주산의학회잡지)
Verma, S. (2020) · Fertility Science and Research · doi:10.4103/2394-4285.288706
Pregnancy Complications & Management Related to Polycystic Ovarian Syndrome: An Overview
Davande, C. C., Gade, A. R., & Kanekar, A. S. (2021) · Cited by 1
Koufakis, T., Garas, A., Zebekakis, P. E., & Kotsa, K. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1942842
“On the other hand, a randomized controlled trial (RCT) failed to replicate such a benefit [12].”
BackgroundVomstein, K. (2020) · Springer eBooks · doi:10.1007/978-3-662-59809-2_6
McIntyre, D. H., & Oats, J. J. N. (2022) · Springer eBooks · doi:10.1007/978-3-030-90684-9_29
Prevention of gestational diabetes mellitus: a minireview
D'Anna, R. (2022) · Italian Journal of Gynaecology and Obstetrics · doi:10.36129/jog.2022.28 · Cited by 2
Considerations and Challenges for Pregnancy in Polycystic Ovary Syndrome
Holliman, K., Wu, E., & Han, C. S. (2022) · Springer eBooks · doi:10.1007/978-3-030-92589-5_16
McIntyre, D. H., Baskerville, C., & Oats, J. J. N. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8684-8_28 · Cited by 2
Polyzystisches Ovarsyndrom (PCOS)
Neumann, K., & Griesinger, G. (2018) · Springer Reference Medizin · doi:10.1007/978-3-662-55601-6_7-1
Lovell, H., Mitchell, A., Ovadia, C., Pitrelli, N., Briley, A. L., Singh, C. M., Marschall, H., Cruickshank, K. J., Murphy, H. R., Seed, P. T., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1455906/v1
Non-Specific Medical Treatment Methods in Female Infertility
Kaplanoğlu, D. K., & Tok, A. (2022) · Düzce Tıp Fakültesi Dergisi · doi:10.18678/dtfd.1191606
Inositol supplementation for preventing gestational diabetes mellitus
Facchinetti, F., D’Anna, R., & Hod, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91673-8.00011-x
Molin, J., Vanky, E., & Bixo, M. (2023) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17493
Self-citationEFFECTIVENESS OF DIETARY INTERVENTIONS IN MANAGING GESTATIONAL DIABETES: A META-ANALYSIS
Kashyap, A., & Sharma, K. N. (2023) · PARIPEX-INDIAN JOURNAL OF RESEARCH · doi:10.36106/paripex/9813015
Metadata
- Authors
- Vanky, E., Stridsklev, S., Heimstad, R., Romundstad, P., Skogøy, K., Kleggetveit, O., Hjelle, S., von Brandis, P., Eikeland, T., Flo, K., Berg, K. F., Bunford, G., Lund, A., Bjerke, C., Almås, I., Berg, A. H., Danielson, A., Lahmami, G., & Carlsen, S. M.
- Affiliations
- Norwegian University of Science and Technology (NO)
- St Olav's University Hospital (NO)
- Department of Public Health (P.R.) Institute of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, 7489 Trondheim, Norway;
- Sentral Hospital of Northern Norway (K.S.), 8092 Bodø, Norway;
- Elvebredden Gynekologpraksis (O.K.), 4630 Kristiansand, Norway;
- Ålesund Hospital (NO)
- Stavanger University Hospital (P.v.B.), 4011 Stavanger, Norway;
- Haugesund Hospital (T.E.), 5504 Haugesund, Norway;
- UiT The Arctic University of Norway (NO)
- Drammen Hospital (NO)
- Ringerike Hospital (G.B.), 5311 Hønefoss, Norway;
- University of Bergen (NO)
- Lillehammer Hospital (C.B., A.H.B., A.D.), 2629 Lillehammer, Norway
- Buskerud Hospital (K.F.B., I.A.), 3004 Drammen, Norway;
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2010-12-01
- Volume
- 95
- Issue
- 12
- Pages
- E448-E455
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1986803895
- Cited by
- 315
- References
- 28
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 18 · 2023: 20 · 2022: 19 · 2021: 22 · 2020: 19 · 2019: 23 · 2018: 24 · 2017: 16 · 2016: 21 · 2015: 17 · 2014: 25 · 2013: 30 · 2012: 20
- FWCI
- 28.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Helse Midt-Norge
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Keywords
- metformin, polycystic ovary syndrome, pregnancy complications, preeclampsia, gestational diabetes mellitus, preterm birth, gestational weight gain, birth weight, first trimester
- MeSH terms
- Adult, Blood Pressure, Double-Blind Method, Female, Heart Rate, Humans, Metformin, Patient Compliance, Placebos, Polycystic Ovary Syndrome, Pre-Eclampsia, Pregnancy, Pregnancy Complications, Pregnancy Trimester, First, Random Allocation, Diabetes, Gestational, Delivery, Obstetric
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.